Skip to content
Telehealth Graded
Prescribing mechanics

Why testosterone is the one telehealth prescription running on a deadline

Every other product on these sites is governed by ordinary prescribing law. Testosterone is not. It is a Schedule III controlled substance, and a 2008 statute says a controlled substance cannot be dispensed over the internet without a prescription written by a practitioner who has done at least one in-person evaluation. The only reason an online testosterone business works at all is a temporary rule, currently in its fourth extension, that expires on December 31, 2026.

Nobody here holds a medical license and none of this is medical advice. Every source below is listed so you can check it yourself.

7
sources cited
4
key takeaways
4
questions answered
September 2026
evidence read

What this comes down to

  • Testosterone is listed by name in the Schedule III anabolic steroid section of the federal drug schedules. Enclomiphene and clomiphene are not listed there at all.
  • The Ryan Haight Act says a valid prescription for a controlled substance dispensed by means of the internet requires a practitioner who has conducted at least one in-person medical evaluation, or a covering practitioner.
  • The exception everyone is operating under is a temporary rule. The fourth extension, published December 31, 2025, is effective January 1, 2026 through December 31, 2026.
  • On our roster the offer has split. Eight sellers price testosterone itself and seven price enclomiphene, which is neither a controlled substance nor an approved drug.

The statute that makes this different

The Ryan Haight Online Pharmacy Consumer Protection Act wrote a specific rule into the Controlled Substances Act: no controlled substance that is a prescription drug may be delivered, distributed or dispensed by means of the internet without a valid prescription, and a valid prescription means one issued for a legitimate medical purpose in the usual course of professional practice by a practitioner who has conducted at least one in-person medical evaluation of the patient, or by a covering practitioner[1]. The statute goes on to define an in-person medical evaluation as one conducted with the patient in the physical presence of the practitioner.

Testosterone falls inside that rule because it is scheduled. The federal drug schedules list it by name under Schedule III anabolic steroids, as testosterone, 17β-hydroxyandrost-4-en-3-one[2]. Nothing about the telehealth model changes that; it changes only which temporary permission the business is relying on.

The permission, and its expiry date

Since 2020 the in-person requirement has been suspended by a series of temporary rules. The current one is the fourth: issued jointly by the Drug Enforcement Administration and the Department of Health and Human Services, published December 31, 2025, effective January 1, 2026 through December 31, 2026[3].

The Drug Enforcement Administration (DEA) jointly with the Department of Health and Human Services (HHS) is issuing a fourth extension of telemedicine flexibilities for the prescribing of controlled medications through December 31, 2026.

[3]
An extension is not a rule

Four extensions in six years is a pattern, and a pattern is not a guarantee. A permanent framework has been proposed and not finalized. If you are being sold a twelve-month prepaid testosterone plan, you are buying across the expiry date of the permission your prescriber is operating under, and the refund terms are the only thing that decides what happens next. Refund and cancellation terms, read in full is where that reading gets done.

The substitute that sidesteps the whole question

Across the 257 sellers on our roster, eight price testosterone itself, from $59 a month, and seven price enclomiphene, from $96 — including Nuform Health, Pomegranate Health, TRT Nation and four more. Enclomiphene is not on the federal schedules, so none of the rules above apply to it. It is also not an approved drug: neither the openFDA label endpoint nor Drugs@FDA returns any product for it, while the same queries return approved products for clomiphene and for testosterone[4].

Clomiphene, the racemic mixture enclomiphene is an isomer of, is approved — for the treatment of ovulatory dysfunction in women desiring pregnancy[5]. That is the entire approved indication. A men's hormone product built on the other isomer is therefore a compounded preparation of an unapproved substance, and the questions that follow are the compounding questions: which pharmacy, which grade of material, and what the beyond-use date rests on. How to check a compounding pharmacy is the short version. What has never been studied is the selling model itself: thirty-three records discuss telemedicine or direct-to-consumer testosterone and none of them is a randomized trial, against 3,328 randomized trials of the molecule[7].

What has been studied about prescribing this way

PubMed, via the E-utilities API

(telemedicine[tiab] OR telehealth[tiab] OR "direct-to-consumer"[tiab]) AND testosterone[tiab] AND "randomized controlled trial"[pt] AND "humans"[mh]

Returned 0. Positive control — testosterone alone, identical trial filter — returned 3328 through the identical filter in the same session.

Thirty-three records discuss telemedicine or direct-to-consumer testosterone at all, and none carries the randomized-trial tag, while the drug itself has 3,328 randomized trials behind it. The control is a very large number on purpose: this is the clearest case on the site of a well-studied molecule and an entirely unstudied way of selling it.

What to ask a men's health service

  • Which molecule are you actually being prescribed? A testosterone plan and an enclomiphene plan are governed by completely different law and neither page usually says so.
  • If it is testosterone, what happens to your prescription if the telemedicine extension is not renewed? The answer should be in the terms, not in a support chat.
  • If it is enclomiphene, which pharmacy compounds it, and is that pharmacy a state-licensed 503A or an FDA-registered outsourcing facility[6]?
  • What does the plan cost after the introductory term, and what is refundable? The calculator is where a membership fee and a medication price stop being the same number.

Questions people actually ask

Is testosterone a controlled substance?

Yes. It is listed by name in the Schedule III anabolic steroid section of the federal drug schedules, which is why prescribing it online is governed by rules that do not apply to a GLP-1.

Can a doctor prescribe testosterone over telehealth without seeing me?

Only under a temporary rule. The underlying statute requires at least one in-person medical evaluation for a controlled substance dispensed by means of the internet. A DEA and HHS temporary rule currently suspends that requirement, and the current extension runs through December 31, 2026.

What happens when the extension expires?

It has been extended four times, and a permanent framework has been proposed rather than finalized. Nobody can tell you what happens next, which is the reason to read a long prepaid plan's cancellation terms before signing one.

Why do so many sites sell enclomiphene instead?

Because it is not a controlled substance, so none of the telemedicine restrictions apply to it. It is also not an approved drug: no product for it appears in either the openFDA label endpoint or Drugs@FDA, which means anything dispensed is a compounded preparation.

Sources

Every source here was fetched and read for this article, with the identifier taken off the record that came back and the claim it supports written down beside it. All of it was read in September 2026, the same session the rest of this page draws on.

  1. 1.
    21 U.S.C. 829 — Prescriptions. Office of the Law Revision Counsel, United States Code, 2026. Source · Document dated September 2026
    Subsection (e) states that no controlled substance that is a prescription drug may be delivered, distributed, or dispensed by means of the Internet without a valid prescription, and defines a valid prescription as one issued for a legitimate medical purpose in the usual course of professional practice by a practitioner who has conducted at least one in-person medical evaluation of the patient, or by a covering practitioner. It defines an in-person medical evaluation as one conducted with the patient in the physical presence of the practitioner. Fetched at HTTP 200 and 162,942 bytes against a nonsense section number returning HTTP 302 with an empty body in the same session.
  2. 2.
    21 CFR 1308.13 — Schedule III. Electronic Code of Federal Regulations, queried through the eCFR versioner API, 2026. Source · Document dated September 2026
    Paragraph (f), Anabolic steroids, lists testosterone (17β-hydroxyandrost-4-en-3-one) by name as item 84 among the substances in Schedule III. A search of the same retrieved section for clomiphene and enclomiphene returned zero occurrences of either. A nonsense section number through the identical endpoint returned HTTP 404 at 69 bytes in the same session.
  3. 3.
    Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications. Drug Enforcement Administration and Department of Health and Human Services, 90 FR 61301, 2025. Source · Document dated December 2025
    A temporary rule, published December 31, 2025 at 90 FR 61301, whose summary is quoted above and whose dates line reads: This rule is effective January 1, 2026 through December 31, 2026. Its background section records the earlier extensions, including a second temporary rule that authorized all DEA-registered practitioners to remotely prescribe Schedules II-V controlled substances without an in-person medical evaluation through December 31, 2024.
  4. 4.
    Structured Product Labeling, queried through the openFDA label API. U.S. Food and Drug Administration, 2026. Source
    Queried on 2026-09-12, both the openFDA label endpoint and the Drugs@FDA endpoint returned HTTP 404 with no match for enclomiphene as a generic name, while the same queries returned approved products for clomiphene (CLOMID, CLOMIPHENE CITRATE) and for testosterone.
  5. 5.
    Clomiphene citrate tablets — FDA prescribing information. U.S. Food and Drug Administration, Structured Product Labeling, 2025. Source · Document dated January 2025
    The record returned for the brand CLOMID carries an SPL effective time of 20250131 and states that clomiphene citrate is indicated for the treatment of ovulatory dysfunction in women desiring pregnancy. No other indication appears in that section.
  6. 6.
    Compounding and the FDA: Questions and Answers. U.S. Food and Drug Administration, 2025. Source · Document dated September 2025
    Drugs compounded in outsourcing facilities are subject to current good manufacturing practice requirements; drugs compounded by a licensed pharmacist in a state-licensed pharmacy under section 503A are not. The page's own line reads Content current as of: 09/16/2025.
  7. 7.
    PubMed, queried through the E-utilities API. National Library of Medicine, 2026. Source
    On 2026-09-12, telemedicine, telehealth or direct-to-consumer terms with testosterone through the randomized-trial and human-indexing filter returned 0; the same terms without the trial filter returned 33; testosterone alone through the identical trial filter returned 3,328.

Key figures

Testosterone's schedule
III
Listed by name among anabolic steroids
Current flexibility expires
December 31, 2026
Randomized trials of telemedicine testosterone
0
Same filter returns 3,328 for testosterone
Approved enclomiphene products
None
Both openFDA endpoints return no match